Pfizer's dual-acting β2 agonists/muscarinic M3 antagonists

被引：0
|
作者：
Norman, Peter [1 ]
机构：
[1] Norman Consulting, Burnham SL1 8JW, Bucks, England
来源：
EXPERT OPINION ON THERAPEUTIC PATENTS | 2008年 / 18卷 / 09期
关键词：
asthma; beta(2) agonist; bronchodilator; COPD; M3; antagonist; MABA; muscarinic antagonist;
D O I：
10.1517/13543776.18.9.1091
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Bifunctional aromatic compounds that contain both beta(2) agonist and muscarinic antagonist pharmacophores linked by a flexible lipophilic spacer are claimed. The compounds display nanomolar potency with respect to both activities and appear designed to provide a long duration of action. The compounds are claimed to be useful in the treatment of both asthma and chronic obstructive pulmonary disease.
引用
收藏
页码：1091 / 1096
页数：6
相关论文
共 50 条
  • [1] Dual-acting β2 agonists/muscarinic antagonists
    Norman, Peter
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (09) : 1327 - 1331
  • [2] New dual-acting bronchodilator treatments for COPD, muscarinic antagonists and beta(2) agonists in combination or combined into a single molecule
    Norman, Peter
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (12) : 1569 - 1580
  • [3] Discovery of long acting inhaled muscarinic M3 receptor antagonists
    Baettig, Urs
    Collingwood, Steve
    Janus, Diana
    Devereux, Nick
    Stanley, Emily
    Cox, Brian
    McCarthy, Clive
    Charlton, Steven
    Leighton-Davis, Juliette
    Fozard, John R.
    Baur, Francois
    Farr, Dave
    Mazzoni, Lazzaro
    Patel, Viral
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 750 - 750
  • [4] Long-acting muscarinic M3 receptor antagonists -: GlaxoSmithKline
    Norman, Peter
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (09) : 1315 - 1320
  • [5] Long-acting muscarinic M3 receptor antagonists -: Theravance
    Norman, Peter
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (09) : 1321 - 1326
  • [6] Inhalation by design: Dual pharmacology β-2 agonists/M3 antagonists for the treatment of COPD
    Jones, Lyn H.
    Baldock, Helen
    Bunnage, Mark E.
    Burrows, Jane
    Clarke, Nick
    Coghlan, Michele
    Entwistle, David
    Fairman, David
    Feeder, Neil
    Fulton, Craig
    Hilton, Laura
    James, Kim
    Jones, Rhys M.
    Kenyon, Amy S.
    Marshall, Stuart
    Newman, Sandra D.
    Osborne, Rachel
    Patel, Sheena
    Selby, Matthew D.
    Stuart, Emilio F.
    Trevethick, Michael A.
    Wright, Karen N.
    Price, David A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (09) : 2759 - 2763
  • [7] Optimized glucuronidation of dual pharmacology β-2 agonists/M3 antagonists for the treatment of COPD
    Hilton, Laura
    Osborne, Rachel
    Kenyon, Amy S.
    Baldock, Helen
    Bunnage, Mark E.
    Burrows, Jane
    Clarke, Nick
    Coghlan, Michele
    Entwistle, David
    Fairman, David
    Feeder, Neil
    James, Kim
    Jones, Rhys M.
    Laouar, Nadia
    Lunn, Graham
    Marshall, Stuart
    Newman, Sandra D.
    Patel, Sheena
    Selby, Matthew D.
    Spence, Fiona
    Stuart, Emilio F.
    Sununerhill, Susan
    Trevethick, Michael A.
    Wright, Karen N.
    Yeadon, Michael
    Price, David A.
    Jones, Lyn H.
    MEDCHEMCOMM, 2011, 2 (09) : 870 - 876
  • [8] Development of dual-acting benzofurans and benzomorpholines as dual thromboxane A2 receptor antagonists and prostacyclin receptor agonists
    Ohno, Michihiro
    Takeda, Takahiro
    Tanaka, Yoichiro
    Makita, Kei
    Miyamoto, Mitsuko
    Yamada, Naohiro
    Ohtake, Atsushi
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2560 - U2560
  • [9] SYNTHESIS OF ANTAGONISTS OF MUSCARINIC (M3) RECEPTORS
    Broadley, Kenneth J.
    Davies, Robin H.
    Escargueil, Christine
    Lee, Alan T. L.
    Penson, Peter
    Thomas, Eric J.
    COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS, 2011, 76 (07) : 781 - 801
  • [10] Neuromuscular relaxants as antagonists for M2 and M3 muscarinic receptors
    Hou, VY
    Hirshman, CA
    Emala, CW
    ANESTHESIOLOGY, 1998, 88 (03) : 744 - 750
12345